31 related articles for article (PubMed ID: 12670568)
1. Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction.
McAuley EM; Mustafi D; Simons BW; Valek R; Zamora M; Markiewicz E; Lamperis S; Williams A; Roman BB; Vezina C; Karczmar G; Oto A; Vander Griend DJ
Am J Pathol; 2017 Nov; 187(11):2378-2387. PubMed ID: 28823870
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent image changes after ethanol injection into the pancreas: an experimental study using a porcine model.
Matsumoto K; Kato H; Tsutsumi K; Fushimi S; Iwamuro M; Oda S; Mizukawa S; Akimoto Y; Uchida D; Tomoda T; Yamamoto N; Horiguchi S; Okada H
Ecancermedicalscience; 2016; 10():663. PubMed ID: 27594908
[TBL] [Abstract][Full Text] [Related]
3. Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Baggish AL; Smith RN; Palacios I; Vlahakes GJ; Yoerger DM; Picard MH; Lowry PA; Jang IK; Fifer MA
Heart; 2006 Dec; 92(12):1773-8. PubMed ID: 16807273
[TBL] [Abstract][Full Text] [Related]
4. Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs.
Chuang YC; Tu CH; Huang CC; Lin HJ; Chiang PH; Yoshimura N; Chancellor MB
BMC Urol; 2006 Apr; 6():12. PubMed ID: 16620393
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous ethanol injection of the prostate as minimally invasive treatment for benign prostatic hyperplasia: preliminary report.
Savoca G; De Stefani S; Gattuccio I; Paolinelli D; Stacul F; Belgrano E
Eur Urol; 2001 Nov; 40(5):504-8. PubMed ID: 11752856
[TBL] [Abstract][Full Text] [Related]
6. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention.
Mutaguchi K; Matsubara A; Kajiwara M; Hanada M; Mizoguchi H; Ohara S; Yasumoto H; Usui T
Urology; 2006 Aug; 68(2):307-11. PubMed ID: 16904442
[TBL] [Abstract][Full Text] [Related]
7. Ethanol injection therapy of the prostate for benign prostatic hyperplasia: preliminary report on application of a new technique.
Goya N; Ishikawa N; Ito F; Ryoji O; Tokumoto T; Toma H; Yamaguchi Y
J Urol; 1999 Aug; 162(2):383-6. PubMed ID: 10411043
[TBL] [Abstract][Full Text] [Related]
8. [The relationship between intravesical prostatic protrusion and pressure flow study findings in patients with benign prostate obstruction/lower urinary tract symptoms].
Park SC; Lee JW; Rim JS
Actas Urol Esp; 2012 Mar; 36(3):165-70. PubMed ID: 22018947
[TBL] [Abstract][Full Text] [Related]
9. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
[TBL] [Abstract][Full Text] [Related]
10. Pilot study of transperineal injection of dehydrated ethanol in the treatment of prostatic obstruction.
Chiang Po; Chuang YC; Huang CC; Chiang CP
Urology; 2003 Apr; 61(4):797-801. PubMed ID: 12670568
[TBL] [Abstract][Full Text] [Related]
11. Tamsulosin for benign prostatic hyperplasia.
Wilt TJ; Mac Donald R; Rutks I
Cochrane Database Syst Rev; 2003; (1):CD002081. PubMed ID: 12535426
[TBL] [Abstract][Full Text] [Related]
12. [Botulinum toxin in the treatment of benign prostatic hyperplasia : an overview].
Boy S; Seif C; Braun PM; Jünemann KP
Urologe A; 2008 Nov; 47(11):1465-71. PubMed ID: 18685825
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
